Soligenix Proof of Concept Uncovers Potential Treatment Option for the World's 125 Million Psoriasis Sufferers
New York, New York--(Newsfile Corp. - November 30, 2021) - PCG Digital -- Proof of concept in the biopharmaceutical sector is a process. Efficacy tests are performed, results are recorded from each round of clinical trials, and formulation changes are made if necessary. Each iteration moves the treatment closer to an NDA filing, with an end goal of achieving FDA approval. The goal is to gather enough data during trials to make that happen. Sometimes, you get more than...
2021-11-30 8:30 AM EST
Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline
New York, New York--(Newsfile Corp. - November 16, 2021) - PCG Digital -- Following a successful merger, one firm is developing and commercializing therapies for rare skin conditions. Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.Key TakeawaysQuoin recently completed a successful merger with Cellect Biotechnology Ltd. and is now trading on the...
2021-11-16 8:30 AM EST
Why Many Expect Nightfood to Be King of the Night Snack Category
New York, New York--(Newsfile Corp. - November 2, 2021) - PCG Digital -- Nightfood (OTCQB: NGTF) is pioneering a new snack category and the biggest companies in the world-including Pepsi, Unilever and Nestle-are already paying attention. Why? The next 12 to 18 months are expected to propel the multi-billion-dollar category opportunity that exists at the intersection of nutrition and sleep. Recently, Nightfood CEO Sean Folkson presented at LD Micro to provide more insight into the company's...
2021-11-02 8:30 AM EDT
Lexaria THC Test Results Come in as MORE Act Gains Momentum in Congress
New York, New York--(Newsfile Corp. - October 20, 2021) - PCG Digital -- Lexaria Bioscience Corp, developers of the revolutionary DehydraTECH™ drug delivery technology, is in the news again this week. On October 13th, the British Columbia-based pharmaceutical company released study results on THC-A21-1, a THC oral format. The study revealed that Lexaria's DehydraTECH™ THC delivers THC levels to blood-plasma at a rate that is roughly three times faster than standard MCT-based THC. Oral...
2021-10-20 8:30 AM EDT
Highlights and Insights into Soligenix
New York, New York--(Newsfile Corp. - October 13, 2021) - PCG Digital -- In a recent interview with Kristen Kluska, a biotechnology analyst at Cantor, Dr. Chris Schaber, President and CEO of Soligenix (NASDAQ: SNGX), spoke about the latest developments with their synthetic hypericin topical treatment HyBryte™ and the Company's ongoing research and development of thermostabilized vaccine candidates for filoviruses and COVID-19. The interview took place at the Cantor Fitzgerald Global Health...
2021-10-13 8:30 AM EDT
Vaccine from Soligenix Could Accelerate Global Recovery from COVID-19 Pandemic
New York, New York--(Newsfile Corp. - October 7, 2021) - PCG Digital -- Shipping and administering COVID-19 vaccines that need to be stored at sub-zero temperatures is hampering the pandemic recovery efforts of health professionals around the world. Soligenix, Inc (NASDAQ: SNGX), a US-based late-stage biopharmaceutical company, is developing a solution to that problem. The Company hit another key milestone this week with its heat-stable vaccine program, CiVax™.On Sept 28, Soligenix announced...
2021-10-07 8:30 AM EDT
DehydraTECH(TM) Nicotine Pouches Could Make Smoking Obsolete
New York, New York--(Newsfile Corp. - October 5, 2021) - PCG Digital -- Lexaria Bioscience Corp (NASDAQ: LEXX) is making headlines again this week. In a study conducted by a leading independent testing facility, DehydraTECH™ 2.0 nicotine pouches easily outperformed generic nicotine benzoate pouches, hitting peak delivery rates within eight minutes, and then again at thirty minutes. The generic pouches hit peak at forty-five minutes.It's a significant disparity when comparing two similar...
2021-10-05 10:48 AM EDT
Nightfood Sleep-Friendly Snacks Enter Hospitality Industry, Helping Hotels Deliver Better Sleep for Guests
Nightfood into their grab-and-go freezers in coming monthsThe brand has engaged iDEAL Hospitality Partners to secure additional hotel distribution partnershipsNightfood believes hotel distribution will greatly advance supermarket sales in the short and long termThe hotel news has not yet moved Nightfood's OTC stockNew York, New York--(Newsfile Corp. - September...
2021-09-21 8:30 AM EDT
Lexaria Takes Another Step Towards NDA Filing for DehydraTECH- CBD
New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The most recent results from HYPER-H21-2, a human clinical study of the effects of Lexaria's DehydraTECHTM-processed CBD on blood pressure (BP) over a 24-hour ambulatory period, have moved the needle significantly in Lexaria's path towards an eventual New Drug Application (NDA). As a precursor to that, the company has begun an Investigational New Drug (IND) enabling program.Volunteers for HYPER-H21-2 who cope with mild...
2021-09-14 8:30 AM EDT
Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics
New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The COVID-19 pandemic has already cost the United States an estimated $16 trillion in lost economic output, and has resulted in the loss of over 600,000 lives. At the end of last month, the country reached the dubious milestone of 39 million diagnosed cases of COVID, however, researchers have estimated a further 4.8 undiagnosed cases per diagnosis, bringing the nation's total number of infections closer to 200...
2021-09-14 8:30 AM EDT
Winning Formulation; Lexaria Takes Strategic Aim at High Value Hypertension and Antiviral Therapeutics Markets with Robust Drug Delivery Technology
Lexaria, delivering active ingredients to patients, could deliver for investors tooThe company that turns CBD into blood pressure control might be poised for a surgeTakeawaysOne critical component to over-the-counter drugs is how efficiently and how quickly (or not) they enter the bloodstream.Lexaria's DehydraTECHTM platform has proven to be an effective method to deliver active ingredients, with human tests demonstrating its ability with CBD as a hypertension treatment and animal tests...
2021-08-17 8:30 AM EDT
Who Is Preparing Us for the Next Potential Pandemic?
New York, New York--(Newsfile Corp. - July 29, 2021) - -- PCG Digital -- Dr. Fauci said it publicly this week, but we've all been thinking it for months now. COVID-19 did not hit us, "out of the blue." Scientists, medical professionals, and researchers have been expecting this for years. The global pandemic was no surprise to them.It will happen again. That's not prophetic gloom and doom. It's scientific fact. With the number of communicable diseases and viruses currently out...
2021-07-29 8:30 AM EDT
Solving the Night Snack Puzzle: Nightfood CEO Sean Folkson Talks Growth, Sleep, and a Billion-Dollar Opportunity
New York, New York--(Newsfile Corp. - July 28, 2021) - PCG Digital -- Nightfood (OCTQB: NGTF), the night snack company, is targeting the $50 billion Americans spend each year on snacks consumed between dinner and bed. Nightfood's award-winning sleep-friendly ice cream was formulated by leading sleep experts to support a good night's sleep for anybody snacking at night. Nightfood's recent results showcase a clean balance sheet, strong management team and key customer additions.With our...
2021-07-28 10:51 AM EDT
EcoChain to Benefit from China's "Great Unplugging" from Crypto
New York, New York--(Newsfile Corp. - July 28, 2021) - PCG Digital -- Chance favors the prepared mind. While the rest of the world is still reeling from China's "unplugging" of cryptocurrency, Michael Toporek, CEO of Mechanical Technologies Inc (NASDAQ: MKTY), sees an opportunity. Their crypto division, EcoChain Inc., is poised to step in, buy up crypto mining equipment, and increase their capacity."Mining profitability is increasing as Chinese miners relocate their equipment and slow down...
2021-07-28 8:30 AM EDT
HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma
New York, New York--(Newsfile Corp. - July 22, 2021) - PCG Digital -- Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin's lymphoma that currently affects between 16,000 - 20,000 Americans, with approximately 1,000 new diagnoses each year. There is currently no FDA-approved first line treatment for CTCL, leaving clinicians and patients reliant on traditional phototherapy treatments. Soligenix (NASDAQ: SNGX), a biopharmaceutical company specializing in treatments for rare diseases,...
2021-07-22 8:30 AM EDT
Nightfood: Go Ahead; Snack Before Bedtime
York, New York--(Newsfile Corp. - July 13, 2021) - PCG Digital -- It's old, familiar, dependable advice: Don't eat right before bed. It's also not necessarily true. Pigging out before bed...
2021-07-13 8:30 AM EDT
QOEG Marketing Strategy Outpaces Competition in Developing Communities
New York, New York--(Newsfile Corp. - July 13, 2021) - PCG Digital -- When it comes to online education, China's Tier 1 cities are saturated. According to Alvin Chau, founder of Quality Online Education Group (OTC: PINK QOEG), "80% of the online education market is located in Tier 2 and Tier 3 cities across the nation." A focus on serving and marketing to less-developed communities in China now leads the education group's robust expansion strategy. In China, a...
2021-07-13 8:30 AM EDT
Offering New Hope for a Rare Form of non-Hodgkin's Lymphoma: A Discussion with Dr. Ellen Kim on HyBryte(TM) from Soligenix
New York, New York--(Newsfile Corp. - July 6, 2021) - PCG Digital -- A rare form of non-Hodgkin's lymphoma, cutaneous T-cell lymphoma (CTCL) has no current FDA-approved first-line therapies. There are roughly 3,000 new CTCL cases in the United States each year, with more than 20,000 patients living with CTCL.Small cap biotech Soligenix (NASDAQ: SNGX) is developing and moving toward potential commercialization of HyBryte™ (SGX301 or synthetic hypericin) as a novel first in class photodynamic...
2021-07-06 8:30 AM EDT
Nightfood: Helping America Rest Easier, One Scoop at a Time
New York, New York--(Newsfile Corp. - June 24, 2021) - PCG Digital -- Let's face it, almost everybody snacks at night. Snacking is comforting after a long day, a way to satisfy cravings when we're tired, stressed or when our emotions get the better of us. But it's not just emotional. Recent research indicates we're actually biologically hard-wired to crave more, and eat more, at night.Americans consume 800 million nighttime snacks each week - and that's just between dinner...
2021-06-24 10:33 AM EDT
Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM)
New York, New York--(Newsfile Corp. - June 17, 2021) - PCG Digital -- Lexaria Bioscience Corp. (NASDAQ: LEXX) hit a major milestone this week with their patented DehydraTECHTM technology. An IC50 in vitro study was completed with COVID-19 SARS-CoV-2 antivirals Remdesivir and Ebastine and concluded that their formulation and processing methodology "did not negate the known efficacy of those compounds." "This test is conducted as a pass/fail," said Chris Bunka, CEO of Lexaria Bioscience. "We...
2021-06-17 8:30 AM EDT